Skip to main content
Have a personal or library account? Click to login
SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health Cover

SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health

Open Access
|Dec 2021

References

  1. WHO approved COVID-19 Vaccine Tracker. World Health Organization [Internet] Last Updated Nov 12, 2021 [cited 2021 Nov 14]. Available from: https://covid19.trackvaccines.org/agency/who/.
  2. Sallam M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021 Feb 16; 9(2): 160. DOI: 10.3390/vaccines9020160
  3. Ministry of Health and Family Welfare. [cited 2021 July 13]. Available from: https://www.mohfw.gov.in/.
  4. Jha A. The numbers behind India’s billion dose landmark. The Indian Express. 2021 Oct 22 [cited 2021 Nov 11]. Available from: https://www.hindustantimes.com/india-news/the-numbers-behind-india-s-billion-dose-landmark-101634831247898.html.
  5. Made-in-India COVID-19 vaccine supplies so far (in lakhs). [Internet]. 2021 May 29 [cited 2021 Nov 11]. Available from: https://www.mea.gov.in/vaccine-supply.htm.
  6. Sheriff MK. Centre flags Tamil Nadu, Kerala for poor vaccine coverage. The Indian Express. 2021 Jan 19 [cited 2021 Jul 24]. Available from: https://indianexpress.com/article/india/centre-flags-tamil-nadu-kerala-for-poor-corona-vaccine-coverage-7151888/.
  7. Sharma M. 60% polled Indians still hesitant towards Covid-19 vaccine, shows survey. India Today. 2021 Jan 26 [cited 2021 Mar 17]. Available from: https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/sixty-percentage-indians-still-hesitant-covid-19-vaccine-survey-1762749-2021-01-26.
  8. Awasthi P. Hesitancy to take Covid-19 vaccine reason for low turnout in India. The Hindu Business Line. 2021 Jan 20 [cited 2021 Mar 17]. Available from: https://www.thehindubusinessline.com/news/covid-19-vaccine-hesitancy-responsible-for-low-turnout-in-india/article33615039.ece.
  9. Bhuyan A. As India Ramps Up COVID-19 Vaccinations, Data On Adverse Events Are Missing. India Spend. 2021 Mar 9 [cited 2021 Mar 17]. Available from: https://www.indiaspend.com/covid-19/as-india-ramps-up-covid-19-vaccinations-data-on-adverse-events-are-missing-733984.
  10. Chandra J. Probe sought into ‘deaths and adverse effects’ after COVID-19 vaccinations. The Hindu. 2021 Mar 17 [cited 2021 Mar 27]. Available from: https://www.thehindu.com/news/national/probe-sought-into-deaths-and-adverse-effects-after-covid-19-vaccinations/article34090356.ece.
  11. Asad S, et al. The Analytical Angle: Vaccine hesitancy in Pakistan is growing. Here’s how it can be tackled. Dawn. 2021 May 11 [cited 2021 Jul 24]. Available from: https://www.dawn.com/news/1620482.
  12. Hashim A. Vaccine hesitancy in Pakistan heightens risk of COVID resurgence. Al Jazeera. 2021 Mar 5 [cited 2021 Mar 27]. Available from: https://www.aljazeera.com/news/2021/3/5/in-pakistan-vaccine-hesitancy-heightens-risk-of-covid-19-resurge.
  13. Abedin M, Islam MA, Rahman FN, et al. (2021). Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage. PLOS ONE. 2021; 16(4): e0250495. DOI: 10.1371/journal.pone.0250495
  14. Paul R. ‘The wait is over’: Bangladesh begins COVID-19 vaccinations. Reuters. 2021 Feb 7 [cited 2021 Mar 27]. Available from: https://www.reuters.com/article/us-health-coronavirus-bangladesh-vaccine-idUSKBN2A70I0.
  15. Agence France-Presse. Interpol warns fake vaccines seized in China and South Africa are ‘tip of iceberg’. The Guardian. 2021 Mar 4 [cited 2021 Mar 17]. Available from: https://www.theguardian.com/world/2021/mar/04/interpol-warns-fake-vaccines-seized-in-china-and-south-africa-are-tip-of-iceberg.
  16. MacRae P. Fears grow that Nepal’s coronavirus crisis could be even worse than India’s. The Coronavirus Pandemic. 2021 May 19 [cited 2021 Jul 24]. Available from: https://www.scmp.com/week-asia/health-environment/article/3134096/while-world-watches-india-neighbouring-nepals-covid-19.
  17. Awale S. Why is there vaccine hesitancy in Nepal? Nepali Times. 2021 Feb 10 [cited 2021 Mar 27]. Available from: https://www.nepalitimes.com/banner/why-is-there-vaccine-hesitancy-in-nepal/.
  18. Awale S. When will Nepal’s Covid vaccine turn come? Nepali Times. 2020 Nov 20 [cited 2021 Mar 27]. Available from: https://www.nepalitimes.com/here-now/when-will-nepals-covid-vaccine-turn-come/.
  19. 1.4 million doses of COVID-19 vaccine arrive in Afghanistan through COVAX global dose-sharing mechanism. Unicef. 2021 Jul 09 [cited 2021 Jul 24]. Available from: https://www.unicef.org/press-releases/14-million-doses-covid-19-vaccine-arrive-afghanistan-through-covax-global-dose.
  20. Afghanistan begins COVID-19 vaccination drive amid rising violence. Reuters. 2021 Feb 23 [cited 2021 Mar 27]. Available from: https://www.reuters.com/article/health-coronavirus-afghanistan-vaccine-i-idUSKBN2AN0Q3.
  21. Shalizi H, Sediqi AQ. Taliban backs vaccine drive as Afghan government receives $112 million funding pledge. Reuters. 2021 Jan 26 [cited 2021 Mar 27]. Available from: https://www.reuters.com/article/us-health-coronavirus-afghanistan-vaccin-idUSKBN29V115.
  22. Wijesinghe MSD, Weerasinghe WMPC, Gunawardana I, Perera SNS, Karunapema RPP. Acceptance of COVID-19 vaccine in Sri Lanka: Applying the health belief model to an online survey. Asia Pac J Public Health. 2021 May 18 Epub ahead of print. PMID: 34000877. DOI: 10.1177/10105395211014975
  23. No deaths in Sri Lanka due to the Covid-19 vaccination drive: Govt. Business Standard. 2021 Mar 20 [cited 2021 Mar 27]. Available from: https://www.business-standard.com/article/pti-stories/no-deaths-in-sri-lanka-due-to-the-covid-19-vaccination-drive-govt-121032000452_1.html.
  24. Bharat Biotech. COVAXIN – India’s First Indigenous Covid-19 Vaccine. c2021 [cited 2021 Mar 27]. Available from: https://www.bharatbiotech.com/covaxin.html.
  25. AstraZeneca. AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19. 2020 Nov 23 [cited 2021 Mar 27]. Available from: https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html.
  26. Serum Institute applies to DCGI to manufacture Covid vaccine Sputnik V. Business Standard. 2021 Jun 03 [cited 2021 Jul 24]. Available from: https://www.business-standard.com/article/current-affairs/serum-institute-applies-to-dcgi-to-manufacture-covid-vaccine-sputnik-v-121060300377_1.html.
  27. Nogrady B. Mounting evidence suggests Sputnik COVID vaccine is safe and effective. Nature. 2021 Jul 06 [cited 2021 Jul 24]. Available from: https://www.nature.com/articles/d41586-021-01813-2.
  28. National Co-Win Statistics. c 2021 [cited 2021 Mar 17]. Available from: https://dashboard.cowin.gov.in/.
  29. Dutt A. 120 million doses ordered as vaccine urgency deepens. Hindustan Times. 2021 Mar 21 [cited 2021 Mar 27]. Available from: https://www.hindustantimes.com/india-news/120mn-doses-ordered-as-vaccine-urgency-deepens-101616264676262.html.
  30. Shukla S. “Will prefer Covishield over Covaxin”: Delhi hospital doctors concerned. 2021, January 17 [cited 2021 November 14]. Available from: https://www.ndtv.com/india-news/give-us-vaccine-that-cleared-all-trials-not-other-one-delhi-rml-hospital-doctors-2353417.
  31. Ahmadi AA. Data deficits around Covaxin contribute to vaccine hesitancy in India. First Draft. 2021 Mar 1 [cited 2021 Mar 27]. Available from: https://firstdraftnews.org/latest/data-deficits-around-covaxin-contribute-to-vaccine-hesitancy-in-india/.
  32. Thacker T. Covaxin gets who approval for emergency use listing. 2021, November 3 [cited 2021 November 14]. Available from: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covaxin-gets-who-approval-for-emergency-use-listing/articleshow/87511805.cms.
  33. What is holding up full rollout of Sputnik V covid vaccine in India? Mint. 2021 Jul 12 [cited 2021 Jul 24]. Available from: https://www.livemint.com/science/news/what-is-holding-up-full-rollout-of-sputnik-v-covid-vaccine-in-india-11626088430328.html.
  34. Baibhawi R. Covid-19: WHO’s assessment of Sputnik V vaccine in final stages, likely to get EUL soon. 2021, October 21 [cited 2021 November 14]. Available from: https://www.republicworld.com/world-news/rest-of-the-world-news/covid-19-whos-assessment-of-sputnik-v-vaccine-in-final-stages-likely-to-get-eul-soon.html.
  35. AstraZeneca. AZD1222 Oxford Phase III trials interim analysis results published in The Lancet. 2020 Dec 8 [cited 2021 Mar 27]. Available at: https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222-oxford-phase-iii-trials-interim-analysis-results-published-in-the-lancet.html.
  36. Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use. The Hindu. 2021 Jan 3 [cited 2021 Mar 27]. Available at: https://www.thehindu.com/news/national/drug-controller-general-approves-covishield-and-covaxin-in-india-for-emergency-use/article33485539.ece.
  37. Bharat Biotech. Bharat Biotech’s ‘COVAXIN™’ emergency use authorization approval by DCGI-CDSCO, MoH&FW, a significant landmark in India’s scientific discovery, and scientists’ capability. Hyderabad. 2021 Jan 03 [cited 2021 Mar 27]. Available at: https://www.bharatbiotech.com/images/press/bharat-biotech-covaxin-emergency-use-authorization-approval-by-dcgi-cdsco-moh-and-fw.pdf.
  38. Kumar NR. Coronavirus | Covaxin efficacy is 81%, works against variants. The Hindu. 2021 Mar 3 [cited 2021 Mar 27]. Available at: https://www.thehindu.com/sci-tech/health/bharat-biotech-says-covid-19-vaccine-shows-81-interim-efficacy/article33980224.ece.
  39. Bharat Biotech’s Covaxin shows 77.8% efficacy in phase 3 trial data: Report. Business Standard. 2021 Jun 22 [cited 2021 Jul 24]. Available from: https://www.business-standard.com/article/current-affairs/bharat-biotech-s-covaxin-shows-77-8-efficacy-in-phase-3-trial-data-report-121062201033_1.html.
  40. Moderna, Inc. Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine. Cambridge. 2020 Dec 31 [cited 2021 Mar 27]. Available from: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-publication-results-pivotal-phase-3-trial#:~:text=On%20November%2030%20%2C%20Moderna%20announced,with%20the%20European%20Medicines%20Agency%20.
  41. Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine. New York and Mainz, Germany. 2020 Dec 10 [cited 2021 Mar 27]. Available at: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-publication-results-landmark.
  42. Mikulic M. Coronavirus (COVID-19): vaccines and vaccination campaign. statista.com. 2021 Mar 26 [cited 2021 Mar 27]. Available at: https://www.statista.com/topics/6172/coronavirus-covid-19-vaccines-and-treatments/.
  43. Bhutta ZA. Beyond informed consent. Bull World Health Organ. 2004 Oct; 82(10): 7717. PMID: 15643799; PMCID: PMC2623030. Available from: https://pubmed.ncbi.nlm.nih.gov/15643799/.
  44. Mathew A. Severe lapses in Covaxin Trials in Bhopal: Consent forms not given, participants who fell ill not treated. 2021, January 07 [cited 2021 November 14]. Available from: https://www.nationalheraldindia.com/india/severe-lapses-in-covaxin-trials-in-bhopal-consent-forms-not-given-participants-who-fell-ill-not-treated.
  45. Leo L. Little recourse for people who are harmed by Covid vaccines. 2021, January 15 [cited 2021 November 14]. Available from: https://www.livemint.com/news/india/little-recourse-for-people-who-are-harmed-by-covid-vaccines-11610669690558.html.
  46. Chandna H. Strict follow-up, informed consent from recipients—Conditions set for cleared Covid vaccines. The Print. 2021 Jan 3 [cited 2021 March 17]. Available from: https://theprint.in/health/strict-follow-up-informed-consent-from-recipients-conditions-set-for-cleared-covid-vaccines/578507/.
  47. Dwivedi S, Tiwari V. Covaxin Taken Off Clinical Trial Mode, No Consent Forms Needed Now. NDTV. 2021 Mar 11 [cited 2021 Mar 17]. Available from: https://www.ndtv.com/india-news/covaxin-taken-off-clinical-trial-mode-no-consent-forms-needed-now-2388808.
  48. Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19. Business Wire. 2020 Dec 2 [cited 2021 Mar 27]. Available from: https://www.businesswire.com/news/home/20201201006304/en/.
  49. U.S. Food and Drug Administration. FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine. 2020 Dec 11 [cited 2021 Mar 27]. Available at: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19.
  50. Cardozo T, Veazey R. Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. Int J Clin Pract. 2020 Oct 28; e13795. Epub ahead of print. PMID: 33113270; PMCID: PMC7645850. Available from: https://pubmed.ncbi.nlm.nih.gov/33113270/. DOI: 10.1111/ijcp.13795.
  51. Mathew A. Severe lapses in Covaxin trials in Bhopal. National Herald. 2021 Jan 7 [cited 2021 Mar 17]. Available from: https://www.nationalheraldindia.com/india/severe-lapses-in-covaxin-trials-in-bhopal-consent-forms-not-given-participants-who-fell-ill-not-treated.
  52. Mukunth V. Covaxin Trial’s Info Sheet Skips Mention of Two Rare but Known Risks – The Wire Science. The Wire. 2021 Jan 29 [cited 2021 Mar 27]. Available from: https://science.thewire.in/health/covaxin-phase-3-clinical-trials-information-sheet-ade-vaerd-informed-consent/.
  53. Bhuyan P, Medin J, da Silva HG, et al. Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis. The Lancet. 2021 Jul 27. DOI: 10.1016/S0140-6736(21)01693-7.
  54. @malini_aisola. AstraZeneca has published a report of 13 cases of TTS, from its global safety database based on its own search criteria. All cases were for AZ vax in UK or EU. Suspected TTS cases, many which have emerged in India post COVISHIELD r NOT being investigated properly. Posted July 28, 2021. Available from: https://web.archive.org/web/20210728132931/https://twitter.com/malini_aisola/status/1420375793457274889.
  55. Gupta UC. Informed consent in clinical research: Revisiting few concepts and areas. erspect Clin Res. 2013 Jan; 4(1): 2632. PMID: 23533976; PMCID: PMC3601699. DOI: 10.4103/2229-3485.106373.
  56. Mitra E, Hollingsworth CJ. More than a dozen slum residents in an Indian city say they didn’t know they were part of a clinical vaccine trial. CNN. 2021 [cited 2021 March 17]. Available from: https://edition.cnn.com/2021/02/25/asia/india-vaccine-trials-covid-ethics-intl-dst-hnk/index.html.
  57. McCormick T. Principles of bioethics. [cited 2021 November 14] Available from: https://depts.washington.edu/bhdept/ethics-medicine/bioethics-topics/articles/principles-bioethics.
  58. Taylor RM. Ethical principles and concepts in medicine. Handb Clin Neurol. 2013; 118: 19. PMID: 24182363. DOI: 10.1016/B978-0-444-53501-6.00001-9
  59. Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemp Clin Trials Commun. 2018; 11: 156164. DOI: 10.1016/j.conctc.2018.08.001
  60. Rao M. India Approves 2 Vaccines For ‘Restricted Emergency Use’ Ahead of Phase 3 Trial Data – Health Policy Watch. Health Policy Watch. 2021 Jan 4 [cited 2021 Mar 27]. Available from: https://healthpolicy-watch.news/india-approves-2-vaccines-for-restricted-emergency-use-ahead-of-phase-3-trial-data/.
  61. Thacker T. Waive bridging trials for fast vaccine rollout: Experts. 2021, March 3 [cited 2021 November 14] Available from; https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/waive-bridging-trials-for-fast-vax-rollout-experts/articleshow/81302195.cms.
  62. Deshpande C. Emergency approval for vaccine has more disadvantages than advantages: IMA. The Times of India. 2020 Dec 5 [cited 2021 Mar 17]. Available from: https://timesofindia.indiatimes.com/city/nagpur/emergency-approval-for-vaccine-has-more-disadvantages-than-advantages-ima/articleshow/79571812.cms.
  63. Institute of Medicine (US) Committee on Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies; Mastroianni AC, Faden R, Federman D (eds.), Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies: Volume I. Washington, DC: National Academies Press (US); 1994. 3, Justice in Clinical Studies: Guiding Principles. Available from: https://www.ncbi.nlm.nih.gov/books/NBK236544/.
  64. World Health Organisation (WHO). WHO Director-General’s opening remarks at 148th session of the Executive Board. Geneva: WHO. 2021 Jan 18 [cited 2021 Mar 27]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-148th-session-of-the-executive-board#:~:text=I%20need%20to%20be%20blunt,in%20the%20world%27s%20poorest%20countries.&text=Vaccine%20equity%20is%20not%20just,a%20strategic%20and%20economic%20imperative.
  65. Unequal Vaccine Distribution Self-Defeating, World Health Organization Chief Tells Economic and Social Council’s Special Ministerial Meeting. United Nations Press release. 2021 Apr 16 [cited 2021 Jul 24]. Available from: https://www.un.org/press/en/2021/ecosoc7039.doc.htm.
  66. Mullard A. How COVID vaccines are being divvied up around the world. Nature. 2020 Nov 30 [cited 2021 Mar 17]. Available from: https://www.nature.com/articles/d41586-020-03370-6. DOI: 10.1038/d41586-020-03370-6.
  67. United Nations. Secretary-General Calls Vaccine Equity Biggest Moral Test for Global Community, as Security Council Considers Equitable Availability of Doses. New York: United Nations Security Council. 2021 Feb 17 [cited 2021 Mar 27]. Available from: https://www.un.org/press/en/2021/sc14438.doc.htm.
  68. Haidar S. India’s COVID-19 vaccine export may be curbed. The Hindu. 2021 March 26 [cited 2021 Mar 27]. Available from: https://www.thehindu.com/news/national/indias-covid-19-vaccine-export-may-be-curbed/article34165333.ece.
  69. Sah P, Vilches TN, Moghadas SM, et al. Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants. EClinicalMedicine. 2021; 35: 100865. DOI: 10.1016/j.eclinm.2021.100865.
DOI: https://doi.org/10.5334/aogh.3530 | Journal eISSN: 2214-9996
Language: English
Published on: Dec 10, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Mohammad Abdullah Sarkar, Ahmad Ozair, Kaushal Kishor Singh, Nishanth R Subash, Mainak Bardhan, Yashita Khulbe, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.